Axcelis Announces Participation in SEMICON China 2026
President and CEO Russell Low will Present Keynote Speech at CS Asia BEVERLY, Mass., March 19, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry,...
TDH Holdings, Inc. Announces Receipt of Nasdaq Notice Regarding Board and Audit Committee Composition Requirements
BEIJING, March 18, 2026 /PRNewswire/ -- TDH Holdings, Inc. (NASDAQ: PETZ) ("TDH" or the "Company"), a PRC-based company that is an owner, operator and manager of commercial real estate properties, announced that it has received a letter from the...
HUYA Inc. Announces New US$50 Million Share Repurchase Program
GUANGZHOU, China, March 18, 2026 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game-related entertainment and services provider, today announced that its board of directors has authorized a new share repurchase program...
Hello Group Inc. Announces Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2025
BEIJING, March 18, 2026 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading player in Asia's online social networking space, today announced its unaudited financial results for the fourth quarter and the full...
YY Group Announces Strategic Investment in Arros AI, an NVIDIA Inception Program Member
AI and Robotics Collaborations, Expanding Manpower Client Portfolio, and Growing IFM Pipeline Reinforce FY2026 Revenue Guidance of US$103 Million to US$110 Million Strengthening Next-Generation Workforce Technology and AI Hiring Infrastructure...
Avex Music Group Announces Global Music Publishing Administration Partnership with Bruno Mars
The deal covers exclusive global publishing administration for music written during the term. LOS ANGELES and TOKYO, March 18, 2026 /PRNewswire/ -- Avex Music Group today announced a global music publishing administration partnership with 16-time...
Innorna Announces FDA Clearance of IND for IN026, Advancing mRNA-based Therapies into Chronic Metabolic Diseases
IN026 is a potential first-in-class mRNA therapy for refractory gout, marking the emergence of a new category of mRNA medicines enabled by Innorna's proprietary mRNA–LNP platform. HONG KONG SAR, China and SHENZHEN, China and CAMBRIDGE, Mass., March...
Meiwu Technology Co Ltd Announces $14 Million Registered Direct Offering
SHENZHEN, China, March 17, 2026 /PRNewswire/ -- Meiwu Technology Co Ltd (NASDAQ: WNW) (the "Company"), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 6,999,996 of...
U POWER Announces Completion of Production of 30 Battery-Swapping Electric Heavy Trucks For Thailand; Pilot Shipment Scheduled for Late May 2026 as Part of 1,000-Vehicle Plan
Thailand Pilot Deployment to Provide Key Insights for Global Battery-Swapping Truck Commercialization BANGKOK, March 17, 2026 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) ("U Power" or the "Company"), a provider of AI-integrated solutions for...
Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306
AP306 is a first-in-class pan-phosphate transporter inhibitor in development for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) receiving dialysis Alebund grants exclusive rights to develop, manufacture, and...